The Food and Drug Administration (FDA) is seeking public comments on a proposed collection of information as part of its requirement for the Office of Management and Budget (OMB) review under the Paperwork Reduction Act of 1995. This initiative pertains to the application process for FDA approval to market new drugs, covering the submission of data and patent details as specified in FDA regulations. The FDA has developed specific forms to aid applicants and has made updates to the process to improve efficiency. Public comments on these proposals are welcomed by March 18, 2021.
Simple Explanation
The FDA is asking for people's thoughts on new rules for making and selling new medicines, and they need these thoughts by March 18, 2021. They want to make the process easier and use special forms to help companies apply.